Discovery of novel plasma proteins as biomarkers for the development of incisional hernias after midline incision in patients with colorectal cancer: The ColoCare study

Surgery (United States)

Volumn 161, Issue 3, 2017, Pages 808-817

  Böhm, Jürgen ^a   Pianka, Frank ^b   Stüttgen, Nina ^b   Rho, Junghyun ^c   Gigic, Biljana ^b   Zhang, Yuzheng ^c   Habermann, Nina ^d   Schrotz King, Petra ^d   Abbenhardt Martin, Clare ^d   Zielske, Lin ^d   Lampe, Paul D ^c   Ulrich, Alexis ^b   Diener, Markus K ^b   Ulrich, Cornelia M ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c USA   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME; RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR; SECONDARY LYMPHOID TISSUE CHEMOKINE; SEX HORMONE BINDING GLOBULIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; PLASMA PROTEIN;

ADULT; ARTICLE; BODY MASS; CANCER SURGERY; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; INCISIONAL HERNIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PILOT STUDY; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; WOUND HEALING; ADVERSE EFFECTS; AGED; BLOOD; COLORECTAL NEOPLASMS; LAPAROTOMY; METABOLISM; POSTOPERATIVE COMPLICATIONS;

AGED; BIOMARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCISIONAL HERNIA; LAPAROTOMY; MALE; MIDDLE AGED; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS;

EID: 85008685952     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2016.08.025     Document Type: Article

References (41)

1. 1 Park, A.E., Roth, J.S., Kavic, S.M., Abdominal wall hernia. Curr Probl Surg 43 (2006), 326–375.
2. 2 Le Huu Nho, R., Mege, D., Ouaissi, M., Sielezneff, I., Sastre, B., Incidence and prevention of ventral incisional hernia. J Visc Surg 149:Suppl 5 (2012), e3–e14.
3. 3 Diener, M.K., Voss, S., Jensen, K., Buchler, M.W., Seiler, C.M., Elective midline laparotomy closure: the INLINE systematic review and meta-analysis. Ann Surg 251 (2010), 843–856.
4. 4 Pereira, J.A., Pera, M., Grande, L., (Trans.) Incidence of incisional hernia after open and laparoscopic colorectal cancer resection Cir Esp 91 (2013), 44–49 [Spanish].
5. 5 Skipworth, J.R., Khan, Y., Motson, R.W., Arulampalam, T.H., Engledow, A.H., Incisional hernia rates following laparoscopic colorectal resection. Int J Surg 8 (2010), 470–473.
6. 6 Bower, C., Roth, J.S., Economics of abdominal wall reconstruction. Surg Clin North Am 93 (2013), 1241–1253.
7. 7 Garcia-Urena, M.A., Lopez-Monclus, J., Hernando, L.A., Montes, D.M., Valle de Lersundi, A.R., Pavon, C.C., et al. Randomized controlled trial of the use of a large-pore polypropylene mesh to prevent incisional hernia in colorectal surgery. Ann Surg 261 (2015), 876–881.
8. 8 Muysoms, F.E., Antoniou, S.A., Bury, K., Campanelli, G., Conze, J., Cuccurullo, D., et al. European Hernia Society guidelines on the closure of abdominal wall incisions. Hernia 19 (2015), 1–24.
9. 9 Pares, D., Shamali, A., Stefan, S., Flashman, K., O'Leary, D., Conti, J., et al. Predictive factors for extraction site hernia after laparoscopic right colectomy. Int J Colorectal Dis 31 (2016), 1323–1328.
10. 10 Brook, A.J., Mansfield, S.D., Daniels, I.R., Smart, N.J., Incisional hernia following closure of loop ileostomy: The main predictor is the patient, not the surgeon. [Epub ahead of print] Surgeon, 2016, 10.1016/j.surge.2016.03.004.
11. 11 Nilsson, J.H., Strandberg Holka, P., Sturesson, C., Incisional hernia after open resections for colorectal liver metastases - incidence and risk factors. HPB (Oxford) 18 (2016), 436–441.
12. 12 Nakayama, M., Yoshimatsu, K., Yokomizo, H., Yano, Y., Okayama, S., Satake, M., et al. Incidence and risk factors for incisional hernia after open surgery for colorectal cancer. Hepatogastroenterology 61 (2014), 1220–1223.
13. 13 Aquina, C.T., Rickles, A.S., Probst, C.P., Kelly, K.N., Deeb, A.P., Monson, J.R., et al. Visceral obesity, not elevated BMI, is strongly associated with incisional hernia after colorectal surgery. Dis Colon Rectum 58 (2015), 220–227.
14. 14 Yamada, T., Okabayashi, K., Hasegawa, H., Tsuruta, M., Abe, Y., Ishida, T., et al. Age, preoperative subcutaneous fat area, and open laparotomy are risk factors for incisional hernia following ccolorectal cancer surgery. Ann Surg Oncol 23:Suppl 2 (2016), S236–S241.
15. 15 Song, I.H., Ha, H.K., Choi, S.G., Jeon, B.G., Kim, M.J., Park, K.J., Analysis of risk factors for the development of incisional and parastomal hernias in patients after colorectal surgery. J Korean Soc Coloproctol 28 (2012), 299–303.
16. 16 van Ramshorst, G.H., Nieuwenhuizen, J., Hop, W.C., Arends, P., Boom, J., Jeekel, J., et al. Abdominal wound dehiscence in adults: development and validation of a risk model. World J Surg 34 (2010), 20–27.
17. 17 Smith, C.T., Katz, M.G., Foley, D., Welch, B., Leverson, G.E., Funk, L.M., et al. Incidence and risk factors of incisional hernia formation following abdominal organ transplantation. Surg Endosc 29 (2015), 398–404.
18. 18 Bucknall, T.E., Cox, P.J., Ellis, H., Burst abdomen and incisional hernia: a prospective study of 1129 major laparotomies. Br Med J 284 (1982), 931–933.
19. 19 George, C.D., Ellis, H., The results of incisional hernia repair: a twelve year review. Ann R Coll Surg Engl 68 (1986), 185–187.
20. 20 Zoller, B., Ji, J., Sundquist, J., Sundquist, K., Shared and nonshared familial susceptibility to surgically treated inguinal hernia, femoral hernia, incisional hernia, epigastric hernia, and umbilical hernia. J Am Coll Surg 217 (2013), 289–299.e1.
21. 21 Klinge, U., Si, Z.Y., Zheng, H., Schumpelick, V., Bhardwaj, R.S., Klosterhalfen, B., Collagen I/III and matrix metalloproteinases (MMP) 1 and 13 in the fascia of patients with incisional hernias. J Invest Surg 14 (2001), 47–54.
22. 22 Guillen-Marti, J., Diaz, R., Quiles, M.T., Lopez-Cano, M., Vilallonga, R., Huguet, P., et al. MMPs/TIMPs and inflammatory signalling de-regulation in human incisional hernia tissues. J Cell Mol Med 13 (2009), 4432–4443.
23. 23 Salameh, J.R., Talbott, L.M., May, W., Gosheh, B., Vig, P.J., McDaniel, D.O., Role of biomarkers in incisional hernias. Am Surg 73 (2007), 561–567 discussion 7-8.
24. 24 Henriksen, N.A., Mortensen, J.H., Sorensen, L.T., Bay-Jensen, A.C., Agren, M.S., Jorgensen, L.N., et al. The collagen turnover profile is altered in patients with inguinal and incisional hernia. Surgery 157 (2015), 312–321.
25. 25 Veljkovic, R., Protic, M., Gluhovic, A., Potic, Z., Milosevic, Z., Stojadinovic, A., Prospective clinical trial of factors predicting the early development of incisional hernia after midline laparotomy. J Am Coll Surg 210 (2010), 210–219.
26. 26 Ristau, J., Staffa, J., Schrotz-King, P., Gigic, B., Makar, K.W., Hoffmeister, M., et al. Suitability of circulating miRNAs as potential prognostic markers in colorectal cancer. Cancer Epidemiol Biomarkers Prev 23 (2014), 2632–2637.
27. 27 Skender, S., Schrotz-King, P., Boehm, J., Abbenhardt, C., Gigic, B., Chang-Claude, J., et al. Repeat physical activity measurement by accelerometry among colorectal cancer patients-feasibility and minimal number of days of monitoring. BMC Res Notes, 8, 2015, 222.
28. 28 Liesenfeld, D., Habermann, N., Toth, R., Owen, R., Frei, E., Böhm, J., et al. Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare). Metabolomics 11 (2015), 998–1012.
29. 29 Rho, J.H., Lampe, P.D., High-throughput screening for native autoantigen-autoantibody complexes using antibody microarrays. J Proteome Res 12 (2013), 2311–2320.
30. 30 Buas, M.F., Rho, J.H., Chai, X., Zhang, Y., Lampe, P.D., Li, C.I., Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study. Breast Cancer Res Treat 153 (2015), 445–454.
31. 31 Rho, J.H., Mead, J.R., Wright, W.S., Brenner, D.E., Stave, J.W., Gildersleeve, J.C., et al. Discovery of sialyl Lewis A and Lewis X modified protein cancer biomarkers using high density antibody arrays. J Proteomics 96 (2014), 291–299.
32. 32 Mirus, J.E., Zhang, Y., Hollingsworth, M.A., Solan, J.L., Lampe, P.D., Hingorani, S.R., Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease. Mol Cell Proteomics 13 (2014), 3484–3496.
33. 33 Smyth, G.K., Speed, T., Normalization of cDNA microarray data. Methods 31 (2003), 265–273.
34. 34 Smyth, G.K., Limma: linear models for microarray data. Gentleman, R., Carey, V.J., Huber, W., Irizarry, R.A., Dudoit, S., (eds.) Bioinformatics and computational biology solutions using R and bioconductor, 2005, Springer New York, New York, 397–420.
35. 35 Frank, M., Kemler, R., Protocadherins. Curr Opin Cell Biol 14 (2002), 557–562.
36. 36 Litvinov, S.V., Velders, M.P., Bakker, H.A., Fleuren, G.J., Warnaar, S.O., Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol 125 (1994), 437–446.
37. 37 Van Marck, V., Stove, C., Van Den Bossche, K., Stove, V., Paredes, J., Vander Haeghen, Y., et al. P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma. Cancer Res 65 (2005), 8774–8783.
38. 38 Sasaki, M., Abe, R., Fujita, Y., Ando, S., Inokuma, D., Shimizu, H., Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 180 (2008), 2581–2587.
39. 39 Ashcroft, G.S., Greenwell-Wild, T., Horan, M.A., Wahl, S.M., Ferguson, M.W., Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 155 (1999), 1137–1146.
40. 40 Tian, Y., Lu, M., Yue, W., Li, L., Li, S., Gao, C., et al. TFIIB-related factor 2 is associated with poor prognosis of nonsmall cell lung cancer patients through promoting tumor epithelial-mesenchymal transition. BioMed Res Int, 2014, 2014, 530786.
41. 41 Awasthi, N., Wagner, B.J., Suppression of human lens epithelial cell proliferation by proteasome inhibition, a potential defense against posterior capsular opacification. Invest Ophthalmol Vis Sci 47 (2006), 4482–4489.